Additionally, the 36-month beta value for GRFS is 0.42. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for GRFS is 258.07M and currently, short sellers hold a 1.15% ratio of that float. The average trading volume of GRFS on April 22, 2025 was 1.08M shares.
GRFS) stock’s latest price update
The stock price of Grifols SA ADR (NASDAQ: GRFS) has surged by 2.92 when compared to previous closing price of 7.01, but the company has seen a 3.07% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-04-08 that MÄNNEDORF, Switzerland–(BUSINESS WIRE)–IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a strategic partnership with Grifols, a global healthcare company and leading producer of plasma-derived medicines and innovative diagnostic solutions, to transform the specialty diagnostics market. Under this collaboration, IBL will develop biomarker panels for specialty diagnostics based on Grifols’ random access, single molecule coun.
GRFS’s Market Performance
GRFS’s stock has risen by 3.07% in the past week, with a monthly drop of -7.38% and a quarterly drop of -1.84%. The volatility ratio for the week is 3.12% while the volatility levels for the last 30 days are 4.67% for Grifols SA ADR The simple moving average for the past 20 days is 2.72% for GRFS’s stock, with a -9.38% simple moving average for the past 200 days.
GRFS Trading at -3.78% from the 50-Day Moving Average
After a stumble in the market that brought GRFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.56% of loss for the given period.
Volatility was left at 4.67%, however, over the last 30 days, the volatility rate increased by 3.12%, as shares sank -7.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.12% upper at present.
During the last 5 trading sessions, GRFS rose by +2.86%, which changed the moving average for the period of 200-days by +8.43% in comparison to the 20-day moving average, which settled at $7.02. In addition, Grifols SA ADR saw -3.02% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRFS
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.39 for the gross margin
The net margin for Grifols SA ADR stands at 0.02. The total capital return value is set at 0.06.
Based on Grifols SA ADR (GRFS), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 1.71. The interest coverage ratio of the stock is 1.67.
Currently, EBITDA for the company is 1.48 billion with net debt to EBITDA at 5.66. When we switch over and look at the enterprise to sales, we see a ratio of 1.97. The receivables turnover for the company is 9.73for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.66.
Conclusion
In conclusion, Grifols SA ADR (GRFS) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
